Evidence map›Paper›PMID 31866807›Full record

ArticleFrontiers in neuroscience2019

Novel and Recurrent Mutations in a Cohort of Chinese Patients With Young-Onset Amyotrophic Lateral Sclerosis.

Jianwen Deng, Wei Wu, Zhiying Xie, Qiang Gang, Meng Yu, Jing Liu, Qingqing Wang, He Lv, Wei Zhang, Yining Huang and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. CGG repeat expansion inProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Article
  9. Review
  10. Genetic analysis in Chinese patients with familial or young-onset amyotrophic lateral sclerosis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Jianwen DengDepartment of Neurology, Peking University First Hospital, Beijing, China.
Wei WuDepartment of Neurology, Peking University First Hospital, Beijing, China.
Zhiying XieDepartment of Neurology, Peking University First Hospital, Beijing, China.
Qiang GangDepartment of Neurology, Peking University First Hospital, Beijing, China.
Meng YuDepartment of Neurology, Peking University First Hospital, Beijing, China.
Jing LiuDepartment of Neurology, Peking University First Hospital, Beijing, China.
Qingqing WangDepartment of Neurology, Peking University First Hospital, Beijing, China.
He LvDepartment of Neurology, Peking University First Hospital, Beijing, China.
Wei ZhangDepartment of Neurology, Peking University First Hospital, Beijing, China.
Yining HuangDepartment of Neurology, Peking University First Hospital, Beijing, China.
Tao WangNational Institute of Biological Sciences, Beijing, China.
Yun YuanDepartment of Neurology, Peking University First Hospital, Beijing, China.
Daojun HongDepartment of Neurology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Zhaoxia WangDepartment of Neurology, Peking University First Hospital, Beijing, China.
Peking University · CNPeking University First Hospital · CNNanchang University · CNNational Institute of Biological Sciences, Beijing · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. More than 25 ALS-related genes have been identified, accounting for approximately 10% of sporadic ALS (SALS) and two-thirds of familial ALS (FALS) cases. Several recent studies showed that genetic factors might have a larger contribution to young-onset ALS than to ALS cases overall. However, the genetic profile of young-onset ALS patients is not yet fully understood. Here, we investigated a cohort of 27 young-onset ALS patients (onset age < 45 years) through whole-exome sequencing (WES). Genetic analysis identified pathogenic variants of

Indexed as

amyotrophic lateral sclerosisc.1528A > C (p. K510Q)Drosophila modelfused in sarcomanovel mutationyoung-onset

Identifiers

PMID31866807
PMCPMC6908997
OpenAlexW2982751627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.